Rationale Varenicline, a smoking-cessation agent, may be useful in treating alcohol use disorders. An important consideration when studying factors that influence drinking/relapse is influence of the pharmacological effects of alcohol on these behaviors. Pre-exposure to alcohol (priming) can increase craving, drinking, and seeking behaviors. Objectives The primary goal of this work was to determine the effects of varenicline on alcohol-primed self-administration and seeking behavior in male Long-Evans rats. Methods First, we assessed whether varenicline (0, 0.3, 1, 3 mg/kg, IP) has alcohol-like discriminative stimulus effects and whether varenicline alters sensitivity to alcohol in rats trained to discriminate a moderate alcohol dose (1 g/kg, IG) vs. water. Second, animals trained to self-administer alcohol underwent assessments to test the effects of: (i) varenicline (0, 0.3, 1, 3 mg/kg, IP) on self-administration, (ii) alcohol priming (0, 0.3, 1 g/kg, IG) on self-administration and seeking behavior, and (iii) varenicline (1 mg/kg) in combination with alcohol priming (1 g/kg) on these behaviors. Results Varenicline did not substitute for alcohol but disrupted the expression of sensitivity to alcohol. Varenicline decreased self-administration but only at a motor-impairing dose (3 mg/kg). Alcohol priming decreased selfadministration and seeking behavior. Varenicline (1 mg/kg) blocked this effect under self-administration conditions, but not seeking conditions, which effectively resulted in increased alcohol intake. Conclusions These findings suggest the importance of further behavioral and mechanistic studies to evaluate the use of varenicline in treating alcohol use disorders and its potential impact on drinking patterns in smokers using varenicline as a smoking-cessation aid.
Introduction
Alcohol use disorders are a continuing world-wide public health issue. For this reason, there is great interest in better understanding behaviors that lead to excessive drinking and developing effective treatments for reducing ongoing drinking and preventing relapse. To date, the US Food and Drug Administration (FDA)-approved treatments for alcohol dependence are naltrexone (opioid antagonist), disulfiram (aldehyde dehydrogenase inhibitor), and acamprosate (actions on GABA and glutamate). These compounds have different mechanisms of action and each have demonstrated efficacy in a limited subset of the patient population (Liang and Olsen 2014) . However, there is continued emphasis on developing novel therapeutics and investigating potential novel pharmacological targets for the treatment of alcohol use disorders (AUDs).
One target that has been receiving increased attention is the nicotinic acetylcholine system. This is of particular interest given that clinical studies show high comorbidity between smoking and heavy drinking (~80 % of heavy drinkers also smoke) and that heavy drinking may influence nicotine dependence (Chatterjee and Bartlett 2010; Dani and Harris 2005; Falk et al. 2006; Grant 1998; McKee et al. 2007) . For this reason, there has been growing interest in the pharmacological compound varenicline for the treatment of AUDs. Varenicline is currently FDA-approved for use as a smoking-cessation agent (Cahill et al. 2012) and is a partial nicotinic acetylcholine receptors (nAChRs) agonist at α4β2, α3β2, and α6 and a full agonist at α3β4 and α7 nAChRs (Coe et al. 2005; Rollema et al. 2009 ). In clinical studies, varenicline has been shown to have efficacy in decreasing alcohol craving and consumption, particularly in smokers (Fucito et al. 2011; Mitchell et al. 2012) . Additionally, evidence from human, nonhuman primates, and rodent studies have shown that varenicline may also be useful in decreasing alcohol consumption and alcoholseeking behaviors (Childs et al. 2012; Feduccia et al. 2014; Hendrickson et al. 2010; Kaminski and Weerts 2014; Litten et al. 2013; McKee et al. 2009; Mitchell et al. 2012; Steensland et al. 2007; Wouda et al. 2011) . Importantly, varenicline appears to selectively attenuate alcohol-related behaviors as compared with naltrexone (Steensland et al. 2007 ).
An important consideration when studying factors that influence drinking and relapse is the influence of the pharmacological effects of alcohol on these behaviors, specifically the role of alcohol priming (e.g., alcohol preexposure leading to additional alcohol consumption or increased craving). Numerous clinical studies have demonstrated that alcohol priming not only increases craving in alcoholics (Hodgson et al. 1979; Ludwig and Wikler 1974) but also increases alcohol-seeking behavior (Bigelow et al. 1977) . Importantly, these effects are not limited to alcohol-dependent individuals. For example, non-dependent social drinkers report increased desire for alcohol following an alcohol priming dose (Kirk and de Wit 2000) . In addition, nonalcoholics tend to choose alcohol over other types of reinforcement and show increased alcohol consumption following an alcohol priming dose (Chutuape and de Wit 1994; de Wit and Chutuape 1993; Hobbs et al. 2005) . In preclinical animal models, an experimenter-administered priming dose of alcohol effectively reinstates alcohol-seeking behavior (Gass and Olive 2007; Le et al. 1998 Le et al. , 1999 Vosler et al. 2001) .
The effects of varenicline on alcohol-primed self-administration and alcohol-seeking behavior have not been previously evaluated, which is important given the impact of priming cues on subsequent drug self-administration and seeking behavior. Therefore, the primary goal of this work was to determine the effects of varenicline on alcohol-primed behavior. Specifically, using operant self-administration methods, the effects of varenicline on maintenance of alcohol selfadministration and alcohol-seeking behavior (under Bprobeextinction^conditions) following alcohol priming injections were assessed. Interestingly, it has been suggested that drugrelated priming effects may be related to the discriminative stimulus/interoceptive effects of the drug (Colpaert 1987; Colpaert et al. 1979; DiChiara and Reinhart 1995; Gerber and Stretch 1975; Jackson et al. 2003; Stolerman 1992; Stretch and Gerber 1973 ). For example, in self-administration models, drugs with similar discriminative stimulus effects as the selfadministered drug may also prime drug-seeking behavior (Anker and Carroll 2010; DiChiara and Reinhart 1995; Fattore et al. 2003; Gerber and Stretch 1975) . Therefore, we first sought to determine whether varenicline has alcohol-like discriminative stimulus effects and whether varenicline pretreatment alters sensitivity to alcohol using standard drug discrimination methods. Rats were trained to discriminate a moderate alcohol dose (1 g/kg) from water. This alcohol training dose was used as it is comparable with alcohol intake achieved in the self-administration experiments. This assessment allows us to determine whether varenicline-induced changes in alcohol priming-related behavior may be related to altered sensitivity to the alcohol priming cue. Within the context of the existing literature showing varenicline-induced decreases in alcohol drinking and self-administration (as discussed above), we hypothesized that varenicline would prevent alcohol priminginduced increases in self-administration and seeking.
Materials and methods

Animals
Thirty-four Long-Evans rats singly housed in ventilated cages were used for these studies. For the discrimination studies in Experiment 1, rats (n=12) were maintained at 325-340 g. For all the self-administration experiments, rats weighed 350-400 g at the beginning of testing and had food and water available ad libitum in the home cage. The following is the breakdown of the rats used in the self-administration experiments (Experiments 2 (n=12), 3 (n=10), 4 (n=9), 5 (n=12), and 6 (n=9)). In an effort to reduce the number of rats required for this work, rats in Experiment 2 were also used in Experiment 5 and rats in Experiment 3 were also used in Experiments 4 and 6 (one rat was not included in these latter experiments due to inconsistent baseline performance). The design of studies and animal use is shown in Fig. 1 . The colony room was maintained on a 12-h light/dark schedule (lights on at 07:00) with all experiments being conducted during the light portion of the schedule. Animals were under continuous care and monitoring by veterinary staff from the Division of Laboratory Animal Medicine (DLAM) at the UNC-Chapel Hill. All procedures were carried out in accordance with the NIH Guide for Care and Use of Laboratory Animals and institutional guidelines. All protocols were approved by the UNC Institutional Animal Care and Use Committee (IACUC). UNC-Chapel Hill is accredited by the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
Behavioral training procedures
Alcohol discrimination training (see Fig. 1 for timeline) Rats were trained using the same behavioral chambers and procedures as previous studies from this laboratory (Besheer et al. 2009 (Besheer et al. , 2012 (Besheer et al. , 2014 . Briefly, immediately following intragastric gavage (IG) administration of alcohol (1 g/kg) or water, rats were placed in the chambers. Following a 10-min delay, both response levers were extended into the chamber (beginning of the 15-min session). On alcohol sessions (i.e., following alcohol administration (1 g/kg, IG)), completion of a fixed ratio 10 (FR10) schedule of reinforcement (e.g., every 10th response) on the alcohol-appropriate lever resulted in presentation of sucrose. Similarly, on water sessions (i.e., following IG water administration), completion of an FR10 on the waterappropriate lever resulted in sucrose delivery. During both alcohol and water sessions, responding on the inappropriate lever was recorded but had no programmed consequence. Testing began once the following criteria were met: the percentage of alcohol-and water-appropriate responses emitted prior to the first reinforcer and during the entire session was >80 % for 8/10 consecutive days.
Testing Test sessions were similar to training sessions except that they were 2 min in duration (following 10 min delay) and completion of an FR10 on either lever resulted in sucrose reinforcement, allowing for assessment of the effects of treatment on overall response rate. Test sessions were interspersed with standard training sessions.
Alcohol self-administration training (see Fig. 1 for timeline) Rats were trained using the same behavioral chambers and procedures as previous studies from this laboratory (Besheer et al. 2010 Cannady et al. 2013) , with the addition of infrared photobeams (that divided the chamber into 4 parallel zones) to measure locomotor activity during sessions (number of beam breaks). Self-administration sessions (30 min) took place 5 days/week (M-F) with both response levers remaining on a fixed ratio 2 (FR2) schedule of reinforcement such that every second response on either lever resulted in delivery of a corresponding reinforcement (i.e., alcohol or water). A sucrose fading procedure was used in which alcohol was gradually added to the 10 % (w/v) sucrose solution. The exact order of exposure was as follows: 10 % sucrose (w/v)/2 % (v/v) alcohol (10S/2A), 10S/5A, 10S/10A, 5S/10A, 5S/ 15A, 2S/15A. There were two sessions at each concentration. Following sucrose fading, sweetened alcohol (2S/15A) and water continued as reinforcers for the remainder of the study.
Experimental procedures (see Fig. 1 ) Experiment 1: effects of varenicline on the discriminative stimulus effects of alcohol To assess whether varenicline has alcohol-like discriminative stimulus effects, rats received varenicline (0, 0.3, 1, 3 mg/kg, IP; n=6) 30 min prior to the start of the discrimination test session. To determine whether varenicline alters the discriminative stimulus effects of the alcohol training dose (1 g/kg), Fig. 1 The experimental design and timeline for the experiments showing training history for the self-administration (SA) experiments and within-group testing. The three separate timelines represent different groups of rats rats received varenicline (0, 0.3, 1, 3 mg/kg, IP; n=6) 20 min prior to alcohol (1 g/kg, IG; i.e., 30 min before the start of the discrimination test session). Within each assessment, doses were assigned in a repeated measures design with each rat receiving all treatments in a randomized order, with at least two baseline sessions between testing days.
Experiment 2: effects of varenicline on maintenance of alcohol self-administration
To assess the effects of varenicline pretreatment on the maintenance of alcohol self-administration, on test days, rats received varenicline (0, 0.3, 1, 3 mg/kg, IP) 30 min prior to a self-administration session. Doses were assigned in a repeated measures design with each rat receiving all treatments in a randomized order, with at least two baseline sessions between testing days. At the conclusion of varenicline testing, the rats were tested to examine locomotor behavior independent of the self-administration procedure as described in Besheer et al. (2013) . Rats received varenicline (0 or 3 mg/kg, IP) 30 min before placement in the locomotor activity chamber. Each rat experienced two 30-min locomotor sessions in which the varenicline dose order was randomized. These locomotor assessments were interspersed with self-administration sessions with at least 3 days between tests. On the locomotor test days, self-administration sessions were withheld.
Experiment 3: effects of alcohol priming on maintenance of alcohol self-administration
To characterize the effects of alcohol priming on ongoing selfadministration, rats received alcohol (0.3, 1.0 g/kg, IG) or water (IG) 10 min prior to a self-administration session. Doses were administered in a repeated measures design with each rat receiving each treatment in a randomized order, with at least two baseline sessions between testing days.
Experiment 4: effects of varenicline on alcohol self-administration following priming
To determine the effects of varenicline on alcohol-primed selfadministration, rats received varenicline (0 or 1 mg/kg, IP) 20 min prior to the alcohol (0 or 1 g/kg, IG) injection and 10 min later underwent a self-administration session. Each rat received each treatment in a randomized order, with at least two baseline sessions between testing days.
Experiment 5: effects of alcohol priming on alcohol-seeking behavior
In order to assess the impact of alcohol priming on the resilience of alcohol-seeking behavior under different conditions, rats were tested under Bprobe-extinction^conditions. For these tests, all cues were activated following completion of each FR2 (i.e., cue light illuminated, pump sound activated); however, no reinforcers were delivered (i.e., no alcohol or water). On test days, rats received the alcohol priming dose (0, 0.3, 1 g/kg, IG) 10 min prior to the session. Rats received each treatment in a randomized order, with at least two baseline sessions between tests.
Experiment 6: effects of varenicline on alcohol-seeking behavior following priming
To determine the effects of varenicline on alcohol-primed seeking behavior, rats received varenicline (0 or 1 mg/kg, IP) 20 min prior to the alcohol (0 or 1 g/kg, IG) injection. Ten minutes later, each rat underwent a Bprobe-extinctionŝ ession as described in Experiment 5. Rats received each treatment in a randomized order, with at least two baseline sessions between testing days.
Drugs
Alcohol (95 %, w/v, Pharmaco-AAPER, Shelbyville, KY) and sucrose were diluted with distilled water for selfadministration sessions. For the alcohol discrimination studies and for all priming injections in the self-administration studies, alcohol was diluted to 20 % (v/v) with distilled water which also served as the water control. Varenicline tartrate (Abcam Pharmaceuticals, Cambridge, UK) was dissolved in 0.9 % saline solution which also served as the vehicle control. Doses for Experiments 1 and 2 were selected based on previous studies (Ginsburg and Lamb 2013; LeSage et al. 2009; Panlilio et al. 2014) . Doses for Experiments 4 and 6 were determined based on the outcome of Experiments 1 and 2. For priming and alcohol discrimination experiments, alcohol was administered via intragastric gavage (IG) with volume varied by rat weight to achieve desired dose. Varenicline was administered via intraperitoneal (IP) injection at a volume of 1 ml/kg.
Statistical analyses
For the discrimination assessments (Experiment 1), alcoholappropriate responses (prior to delivery of the first reinforcer) and response rates were analyzed with one-way repeated measures analysis of variance (RM ANOVA). For the selfadministration experiments, alcohol intake (g/kg) was approximated based on body weight and number of reinforcements delivered. For all single treatment experiments (i.e., varenicline alone or alcohol prime alone), total alcohol responses, water responses, alcohol intake (g/kg), and total locomotion were analyzed with one-way repeated measures ANOVA. For experiments in which two treatment types were used (i.e., alcohol prime and varenicline), two-way repeated measures factorial ANOVA (with prime condition and varenicline dose as factors) was used. To assess changes in response patterns over time, multi-factor ANOVA was used with prime condition, varenicline condition and time point as factors. Post hoc analysis (Tukey) was used to determine differences between specific treatment conditions. Statistical significance was determined at p≤0.05.
Results
Experiment 1: effects of varenicline on the discriminative stimulus effects of alcohol Varenicline administered alone had no alcohol-like discriminative stimulus effects, as alcohol-appropriate responses were below the substitution threshold (80 %) and did not significantly differ from saline (Fig. 2a) . A significant effect on response rate was observed (F[3, 15] =3.60, p=0.04; Fig. 2b) ; however, post hoc analyses did not detect any significant differences. In contrast, varenicline pretreatment altered sensitivity to the discriminative stimulus effects of the alcohol training dose (1 g/kg) . RM ANOVA showed a significant vareniclineinduced decrease in alcohol-appropriate responses (F[3, 15]= 9.682, p<0.01; Fig. 2c) , with decreased alcohol-appropriate responses following 1.0 and 3.0 mg/kg varenicline doses as compared with saline (p<0.05). Additionally, RM ANOVA showed a significant varenicline-induced reduction in response rate (F[3, 15] =7.677, p<0.01; Fig. 2d ), at the highest varenicline dose (3.0 mg/kg) as compared with saline (p<0.05), indicating the likely disruption of motor behavior. Together, these results show that varenicline does not substitute for the discriminative stimulus effects of alcohol, and when administered prior to alcohol disrupts sensitivity to/ alters the discriminative stimulus effects of a moderate alcohol dose (1 g/kg). Fig. 4b ) but no alcohol dose by time interaction. Total water lever responses (Table 1 ) and total locomotion (Table 3) were not affected by alcohol priming. Interestingly, alcohol intake (g/kg) following the water prime was lower than baseline ( Table 2 ), indicating that self-administration behavior was likely affected by the oral fluid administration. Indeed, previous studies have demonstrated that alcohol intake following oral administration of 2 ml of a subthreshold dose of alcohol decreases subsequent alcohol intake compared with a zero volume control (Czachowski et al. 2006 ). Table 2 ) was also observed, with significantly greater alcohol responding following varenicline (1 mg/kg) pretreatment relative to saline (p<0.05; Fig. 5a ) and an alcohol priming-induced reduction in alcohol lever responses following vehicle pretreatment (p<0.05; Fig. 5a ). Interestingly, the alcohol-priming effect was not observed following varenicline pretreatment, suggesting that varenicline blocked or counteracted the effects of priming. Similar to the data pattern observed in Experiment 3, alcohol intake (g/kg) following the water prime was lower than baseline (Table 2 ). There were no effects on total water lever responses (Table 1) or total locomotion (Table 3) .
Examination of the pattern of alcohol responses across the session by RM factorial ANOVA showed a significant decrease in alcohol responding across the session (F[5, 40]= 17.270, p < 0.01; Fig. 5b ). There was no priming by varenicline treatment interaction on alcohol lever responses. Additionally, alcohol lever responses across time showed a Baseline intake (g/kg) from session prior to beginning of testing *p<0.05 denotes significant difference from 0 Experiment 5: effects of alcohol priming on alcohol-seeking behavior Baseline alcohol intake (session prior to testing) was 0.80± 0.1 g/kg. Alcohol priming significantly reduced alcoholseeking behavior as indicated by a RM ANOVA (F[2, 22]= 9.785, p<0.001; Fig. 6a) , with less alcohol lever responses compared with water (p<0.05). Analysis of alcohol responses across the session showed a significant main effect of time (F[5, 55] =21.966, p<0.01; Fig. 6b ) and an alcohol dose by time interaction (F[10, 110] =3.257, p<0.01). Post hoc analysis showed that rats primed with alcohol (0.3 and 1.0 g/kg) responded less in the first 5 min compared with water pretreatment. Priming had no effects on total water lever responses (Table 1) or total locomotion (Table 3) .
Experiment 6: effects of varenicline on alcohol-seeking behavior following priming Baseline alcohol intake (session prior to testing) was 0.76± 0.1 g/kg. Two-way RM ANOVA showed a main effect of alcohol priming on total alcohol lever responses (F[1, 8]=20 .537, Fig. 7a) , with a significant reduction observed following alcohol (1 g/kg) compared with water (p < 0.05). Furthermore, there was a significant main effect of varenicline treatment on total alcohol lever responses (F[1, 8]=5 .999, p<0.05), with a significant increase following varenicline (1 mg/kg) compared with saline treatment (p<0.05). There was no priming by varenicline treatment interaction on alcohol lever responses. Post hoc analysis confirmed an alcohol priming-induced reduction in alcohol lever responses following both vehicle and varenicline pretreatment (p<0.05). Analysis of response patterns across the probe-extinction session showed a reduction in alcohol lever responses over time (F[5, 40] =8.356, p<0.01; Fig. 7b ). Furthermore, following alcohol priming, there was a greater reduction in lever pressing compared with water priming (F[1, 32]=12.617, p<0.05) . Conversely, lever pressing remained higher over time following varenicline treatment compared with saline (F[1, 32]=5.109, p<0.05). There were no interactions between treatments or between treatments and time period. Total water lever responses (Table 1) and total locomotion (Table 3) was not affected by any treatment condition.
Discussion
The current experiments demonstrate several important findings. First, in the dose range tested, varenicline does not have alcohol-like effects similar to a moderate dose of alcohol (1 g/kg). However, varenicline is capable of disrupting the discriminative stimulus effects of alcohol (1 g/kg) at a dose that did not alter response rate (1 mg/kg; Fig. 2c, d) . Next, varenicline pretreatment decreased alcohol self-administration ( Fig. 3 ) but only at a high dose (3 mg/kg) that also reduced locomotion during the self-administration session (Table 3) , in an independent assay, and as reflected by reduced response rate in the discrimination study (Fig. 2d) . Therefore, selfadministration was not selectively reduced by varenicline pretreatment. Consistent with this finding, is other work in which a dose of 1.8 mg/kg varenicline or greater non-selectively decreased alcohol self-administration behavior (Ginsburg and Lamb 2013) . The lack of a selective effect of varenicline on alcohol self-administration is in contrast to other operant alcohol self-administration studies that show a vareniclineinduced decrease in self-administration (Steensland et al. 2007; Wouda et al. 2011) . Several factors may contribute to these differential effects, including alcohol self-administration history (daily g/kg, duration of training), response requirements, and strain. Indeed, recently, varenicline has been shown to have differential effects on alcohol and foodrelated behaviors depending on the operant testing conditions (Ginsburg and Lamb 2014) . Additionally, varenicline has also been shown to reduce voluntary alcohol drinking under home cage drinking conditions (Feduccia et al. 2014; Steensland et al. 2007) ; however, given the lack of a specific work requirement (i.e., lever press, nose poke) under those conditions, direct comparison with the present work is difficult. Lastly, we found that varenicline prevented an alcohol-primed decrease in self-administration (Fig. 5 ), resulting in potentiated alcohol self-administration relative to vehicle pretreatment. In contrast, under Bprobe-extinction^conditions, the alcoholprimed decrease in alcohol-seeking behavior was unaffected by varenicline (Fig. 7) .
An important aspect of the current studies was to assess the role of alcohol priming under self-administration and alcoholseeking (Bprobe-extinction^) conditions. Alcohol priming (1 g/kg) reliably decreased alcohol self-administration (Experiments 3 and 4). These findings are in line with several previous studies that suggest that this effect is evidence for rats titrating intake based on the priming dose (Czachowski et al. , 2006 Samson and Czachowski 2003) . However, it is important to note, that even though self-administration is reduced following priming (1 mg/kg), the amount of total alcohol exposure following the self-administration session (which includes the priming dose), is greater than the water-primed rats (~1.3 vs. 0.6 g/kg, respectively). Interestingly, priming was more effective at decreasing behavior under alcoholseeking conditions (Experiment 5), as both alcohol doses tested (0.3 and 1 g/kg) similarly decreased seeking behavior (Fig. 6 ). This suggests that alcohol-seeking behavior is more sensitive than self-administration behavior to alcohol priming. Consistent with this finding, is work by Jackson et al. (2003) in which alcohol priming (0.5 g/kg) significantly decreased alcohol-seeking behavior during probe-extinction tests similar to the strategy incorporated in the present work. However, together, these findings are in contrast to those from reinstatement studies in which alcohol-seeking behavior is potentiated following alcohol priming at doses similar to those employed in the present work (Le et al. 1998 (Le et al. , 1999 Samson and Chappell 2002) . These different data patterns suggest that following extended periods of explicitly trained extinction and/or the consequent absence from alcohol (as employed in reinstatement studies), the functional impact of an alcohol priming cue to modulate behavior is increased compared with probe extinction trials as used in this work and by Jackson et al. (2003) . Interestingly, the consequences of varenicline pretreatment on alcohol priming varied under the different testing conditions. That is, under self-administration conditions (e.g., alcohol is available) varenicline blocked the effects of alcohol priming on self-administration, which resulted in potentiated self-administration relative to the vehicle control (i.e., selfadministration at levels similar to the water-primed controls; Fig. 5 ). In contrast, under seeking conditions (i.e., Bprobeextinction^) varenicline pretreatment did not alter alcoholprimed seeking behavior (Fig. 7) . A plausible explanation for the potentiation of self-administration behavior is that varenicline decreased sensitivity to the interoceptive effects of the alcohol priming dose, such that the priming cue no longer effectively regulated behavior. Indeed, this potential explanation is supported by the findings of Experiment 1. This disruption in sensitivity to alcohol may be related to varenicline having interoceptive effects of its own that compete with alcohol. Indeed, varenicline has been shown to have methamphetamine-like discriminative stimulus effects (Desai and Bergman 2014) . Furthermore, Ginsburg and Lamb (2013) demonstrate that varenicline (1 mg/kg) increases alcohol selfadministration, potentially through stimulant-like effects. However, this explanation cannot account for the lack of effect of varenicline pretreatment under seeking conditions.
In order to better understand the differences between the effects of varenicline on self-administration and seeking conditions, response patterns across the session were examined. Under self-administration conditions (Experiment 4), a significant varenicline-induced increase in alcohol responses occurred early in the session (Fig. 5b) , consistent with previous work (Ginsburg and Lamb 2013) . In contrast, under seeking conditions (Experiment 6) no varenicline-induced increase in responding was observed at any point during the session, although a trend was observed early in the session (Fig. 7b ). These differences in response patterns may, in part, be explained by different testing conditions. The combination of varenicline, alcohol priming, and the availability of alcohol in Experiment 4 may have led to the appropriate conditions under which motivation for alcohol-reinforced lever pressing was enhanced. In contrast, alcohol was not available in Experiment 6 (i.e., extinction session), potentially contributing to the decrease in responding observed. These findings demonstrate the importance of testing conditions in evaluating the effects of priming and the role of varenicline.
In the present work, the effects of a single varenicline dose to modulate a single alcohol priming dose were assessed. The varenicline dose was selected based on the results of the initial self-administration experiment (Experiment 2), in that it was necessary to select a dose that did not negatively impact motor behavior. The alcohol priming dose was selected based on the finding that pretreatment with a moderate alcohol dose (1 g/kg) effectively reduced subsequent self-administration and alcohol-seeking behavior (Experiments 3 and 5, respectively). However, it will be informative for future work to examine a dose range of both compounds. Additionally, the current experiments were undertaken in a non-dependence model of alcohol intake. Varenicline has been shown to be effective at reducing alcohol consumption in individuals that have been heavy drinkers for many years (for review, see Erwin and Slaton 2014); therefore, it will be interesting to examine the effects of varenicline on operant self-administration under conditions of dependence. Moreover, the behavioral profile of varenicline in the present study (i.e., lack of selective effect of varenicline on operant alcohol self-administration, disruption of sensitivity to the discriminative stimulus effects of alcohol, and reduced ability of alcohol priming to appropriately regulate self-administration behavior), suggests that varenicline may actually present a risk factor for nondependent drinkers (e.g., social drinkers) using varenicline as a smoking-cessation aid. Interestingly, one of the label indications for varenicline is the recommendation that individuals prescribed varenicline to quit smoking reduce their alcohol consumption while taking the drug. As such, further mechanistic and behavioral studies are needed to characterize the therapeutic value of varenicline in the treatment of alcohol use disorders, and also the potential impact on drinking patterns in social drinkers, especially those using varenicline as a smoking-cessation aid.
